MR. GILLESPIE: My name is Dick Gillespie. I'm chairman of the Virginia Prostate Cancer Coalition. I also run a very successful Us TOO group.
My cancer is low-grade, but within my group there are a number of senior individuals, basically, whose hormone therapy is no longer working. They're sort of bereft of hope, and they're scared to death of chemotherapy. And to bring a little more - something more personal in this thing, one of the members of my prostate cancer support group, my neighbor, was one of the most conscientious individuals in learning new procedures and following them. All of a sudden he got to the point, hormone therapy really was not working anymore, and it - we had a speaker
from the National Cancer Institute come over and talk about vaccines. After that, he went up and talked to them and the individuals felt very strongly he should get into the clinical trial program, probably on Provenge. His health wasn't quite up to it, however, and before he was able to start, the PSA really spiked. He was put on Taxotere. Taxotere, the side effects drove his white blood cells and his red blood cells down to nothing. He went into the hospital for a whole series of blood transfusions. From there on in, his demise was painful and quick. Here again, as I review my own relationship with my neighbor over there, if he had Provenge this all might have been prevented. Thank you.
(Applause)
DR. MULÃ: Thank you, Mr. Gillespie.
